Intrapulmonary concentrations of antimicrobial agents

Research output: Contribution to journalArticle

49 Citations (Scopus)

Abstract

The delivery of antimicrobial agents to the site of infection has always been considered important. Lung infections are typically localized to the bronchial mucosa, endothelial lining fluid, and/or alveolar macrophages. Significant advances have been made in measuring antimicrobial concentrations at these sites, although some of the methods need further refinement and standardization. Relating various intrapulmonary site concentrations to efficacy or treatment failure requires further study. This article reviews the theory and methods relating to the measurement of intrapulmonary delivery of antimicrobial agents, and compares the intrapulmonary delivery of agents commonly used for the treatment of lower respiratory infections.

Original languageEnglish (US)
Pages (from-to)631-646
Number of pages16
JournalInfectious Disease Clinics of North America
Volume12
Issue number3
StatePublished - 1998

Fingerprint

Anti-Infective Agents
Alveolar Macrophages
Infection
Treatment Failure
Respiratory Tract Infections
Mucous Membrane
Lung

ASJC Scopus subject areas

  • Microbiology (medical)

Cite this

Intrapulmonary concentrations of antimicrobial agents. / Nix, David E.

In: Infectious Disease Clinics of North America, Vol. 12, No. 3, 1998, p. 631-646.

Research output: Contribution to journalArticle

@article{b4a3083c33624ee2a80e6d1cd7b161dd,
title = "Intrapulmonary concentrations of antimicrobial agents",
abstract = "The delivery of antimicrobial agents to the site of infection has always been considered important. Lung infections are typically localized to the bronchial mucosa, endothelial lining fluid, and/or alveolar macrophages. Significant advances have been made in measuring antimicrobial concentrations at these sites, although some of the methods need further refinement and standardization. Relating various intrapulmonary site concentrations to efficacy or treatment failure requires further study. This article reviews the theory and methods relating to the measurement of intrapulmonary delivery of antimicrobial agents, and compares the intrapulmonary delivery of agents commonly used for the treatment of lower respiratory infections.",
author = "Nix, {David E.}",
year = "1998",
language = "English (US)",
volume = "12",
pages = "631--646",
journal = "Infectious Disease Clinics of North America",
issn = "0891-5520",
publisher = "W.B. Saunders Ltd",
number = "3",

}

TY - JOUR

T1 - Intrapulmonary concentrations of antimicrobial agents

AU - Nix, David E.

PY - 1998

Y1 - 1998

N2 - The delivery of antimicrobial agents to the site of infection has always been considered important. Lung infections are typically localized to the bronchial mucosa, endothelial lining fluid, and/or alveolar macrophages. Significant advances have been made in measuring antimicrobial concentrations at these sites, although some of the methods need further refinement and standardization. Relating various intrapulmonary site concentrations to efficacy or treatment failure requires further study. This article reviews the theory and methods relating to the measurement of intrapulmonary delivery of antimicrobial agents, and compares the intrapulmonary delivery of agents commonly used for the treatment of lower respiratory infections.

AB - The delivery of antimicrobial agents to the site of infection has always been considered important. Lung infections are typically localized to the bronchial mucosa, endothelial lining fluid, and/or alveolar macrophages. Significant advances have been made in measuring antimicrobial concentrations at these sites, although some of the methods need further refinement and standardization. Relating various intrapulmonary site concentrations to efficacy or treatment failure requires further study. This article reviews the theory and methods relating to the measurement of intrapulmonary delivery of antimicrobial agents, and compares the intrapulmonary delivery of agents commonly used for the treatment of lower respiratory infections.

UR - http://www.scopus.com/inward/record.url?scp=0031679439&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0031679439&partnerID=8YFLogxK

M3 - Article

C2 - 9779382

AN - SCOPUS:0031679439

VL - 12

SP - 631

EP - 646

JO - Infectious Disease Clinics of North America

JF - Infectious Disease Clinics of North America

SN - 0891-5520

IS - 3

ER -